Despite Survival Benefit With CABG, More Diabetic Patients With MVD Still Treated With PCI (Dr. Krishnan Ramanathan)
Real-world data again support the role of CABG over PCI in diabetic patients with multivessel CAD—especially those with stable ACS—yet PCI continues to be a common option for this patient population, according to analysis of 2 Canadian registries.
“Our findings are consistent with … the FREEDOM trial,” and reconfirm the survival benefit of CABG in this group of patients, said Krishnan Ramanathan, MD, of the University of British Columbia (Vancouver, Canada), in his presentation last week at the American Heart Association 2015 Scientific Sessions.
Sourcing data from 2 registries in British Columbia, the investigators looked at 4,819 revascularizations—2,888 PCI cases (68.1% stabilized ACS) and 1,931 CABG procedures (54.4% stabilized ACS)—performed between October 2007 and January 2014 in patients with diabetes and multivessel disease.
Yael L. Maxwell reports.
Angela White, St. Paul's Hospital Volunteer